Convatec Group Plc Hits Day Low of GBP 2.27 Amid Price Pressure
Convatec Group Plc, a mid-cap in the Pharmaceuticals & Biotechnology sector, saw its stock decline significantly during trading. Despite a year-to-date increase, its performance lags behind the FTSE 100. The company has shown modest growth in operating profit and maintains a notable debt-to-equity ratio and return on equity.
Convatec Group Plc, a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 6.18%. The stock reached an intraday low of GBP 2.27, reflecting a challenging trading session. In terms of performance metrics, Convatec has shown a year-to-date increase of 4.25%, although this is significantly overshadowed by the FTSE 100's performance of 18.38% during the same period. Over the past year, Convatec's stock has generated a return of -3.31%, while its profits have increased by 16.3%. The company's operating profit has grown at an annual rate of 8.16% over the last five years, indicating some growth, albeit at a modest pace.
Convatec's financial profile includes a debt-to-equity ratio of 0.65 and a return on equity of 13.52%. However, its price-to-book ratio stands at 3.60, suggesting a relatively high valuation compared to its book value. As the company navigates these market dynamics, its performance continues to be closely monitored within the industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
